This study will now serve as a fundamental basis for further mechanistic investigations into the role of the TWEAK/Fn14 pathway, not only in established pancreatic disease, but also to therapeutically target Fn14 downstream effects for regulating the tissue microenvironment in chronic pancreatitis. The gene discussed is TNFRSF12A; the disease is chronic pancreatitis.